These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 10893639

  • 1. Detection of hematogenous micrometastasis in patients with transitional cell carcinoma.
    Güdemann CJ, Weitz J, Kienle P, Lacroix J, Wiesel MJ, Soder M, Benner A, Staehler G, Doeberitz MV.
    J Urol; 2000 Aug; 164(2):532-6. PubMed ID: 10893639
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Quantitative detection of cytokeratin 20 mRNA expression in bladder carcinoma by real-time reverse transcriptase-polymerase chain reaction.
    Christoph F, Müller M, Schostak M, Soong R, Tabiti K, Miller K.
    Urology; 2004 Jul; 64(1):157-61. PubMed ID: 15245962
    [Abstract] [Full Text] [Related]

  • 4. Molecular staging of bladder cancer with RT-PCR assay for CK20 in peripheral blood, bone marrow and lymph nodes: comparison with standard histological staging.
    Ribal MJ, Mengual L, Marín M, Algaba F, Ars E, Fernández PL, Oliva R, Villavicencio H, Alcaraz A.
    Anticancer Res; 2006 Jul; 26(1A):411-9. PubMed ID: 16475726
    [Abstract] [Full Text] [Related]

  • 5. Expression of cytokeratin 20 in urinary cytology of patients with bladder carcinoma.
    Klein A, Zemer R, Buchumensky V, Klaper R, Nissenkorn I.
    Cancer; 1998 Jan 15; 82(2):349-54. PubMed ID: 9445193
    [Abstract] [Full Text] [Related]

  • 6. Detection of circulating tumor cells by cytokeratin 20 and prostate stem cell antigen RT-PCR in blood of patients with gastrointestinal cancers.
    Lukyanchuk VV, Friess H, Kleeff J, Osinsky SP, Ayuni E, Candinas D, Roggo A.
    Anticancer Res; 2003 Jan 15; 23(3B):2711-6. PubMed ID: 12894563
    [Abstract] [Full Text] [Related]

  • 7. Detection of disseminated colorectal cancer cells in lymph nodes, blood and bone marrow.
    Weitz J, Kienle P, Magener A, Koch M, Schrödel A, Willeke F, Autschbach F, Lacroix J, Lehnert T, Herfarth C, von Knebel Doeberitz M.
    Clin Cancer Res; 1999 Jul 15; 5(7):1830-6. PubMed ID: 10430088
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Detection of epidermal growth factor receptor mRNA in peripheral blood: a new marker of circulating neoplastic cells in bladder cancer patients.
    Gazzaniga P, Gandini O, Giuliani L, Magnanti M, Gradilone A, Silvestri I, Gianni W, Gallucci M, Frati L, Aglianò AM.
    Clin Cancer Res; 2001 Mar 15; 7(3):577-83. PubMed ID: 11297251
    [Abstract] [Full Text] [Related]

  • 11. Disseminated tumor cells in bone marrow of patients with transitional cell carcinoma: immunocytochemical detection and correlation with established prognostic indicators.
    Hofmann T, Riesenberg R, Buchner A, Zimmermann W, Hofstetter A, Oberneder R.
    J Urol; 2003 Apr 15; 169(4):1303-7. PubMed ID: 12629348
    [Abstract] [Full Text] [Related]

  • 12. Cytokeratin 20: a new marker for early detection of bladder cell carcinoma?
    Buchumensky V, Klein A, Zemer R, Kessler OJ, Zimlichman S, Nissenkorn I.
    J Urol; 1998 Dec 15; 160(6 Pt 1):1971-4. PubMed ID: 9817302
    [Abstract] [Full Text] [Related]

  • 13. Cytokeratin 20 is not a tissue-specific marker for the detection of malignant epithelial cells in the blood of colorectal cancer patients.
    Bustin SA, Gyselman VG, Siddiqi S, Dorudi S.
    Int J Surg Investig; 2000 Dec 15; 2(1):49-57. PubMed ID: 12774338
    [Abstract] [Full Text] [Related]

  • 14. Detection of circulating gastric cancer cells in peripheral blood using real time quantitative RT-PCR.
    Koga T, Tokunaga E, Sumiyoshi Y, Oki E, Oda S, Takahashi I, Kakeji Y, Baba H, Maehara Y.
    Hepatogastroenterology; 2008 Dec 15; 55(84):1131-5. PubMed ID: 18705345
    [Abstract] [Full Text] [Related]

  • 15. Immunocytochemical detection of circulating esophageal carcinoma cells by immunomagnetic separation.
    Nakamura T, Yasumura T, Hayashi K, Eguchi R, Ide H, Takasaki K, Kasajima T.
    Anticancer Res; 2000 Dec 15; 20(6C):4739-44. PubMed ID: 11205210
    [Abstract] [Full Text] [Related]

  • 16. Quantitative detection of cytokeratin 20 mRNA in urine samples as diagnostic tools for bladder cancer by real-time PCR.
    Guo B, Luo C, Xun C, Xie J, Wu X, Pu J.
    Exp Oncol; 2009 Mar 15; 31(1):43-7. PubMed ID: 19300416
    [Abstract] [Full Text] [Related]

  • 17. Detection of circulating cancer cells by reverse transcription-polymerase chain reaction for uroplakin II in peripheral blood of patients with urothelial cancer.
    Lu JJ, Kakehi Y, Takahashi T, Wu XX, Yuasa T, Yoshiki T, Okada Y, Terachi T, Ogawa O.
    Clin Cancer Res; 2000 Aug 15; 6(8):3166-71. PubMed ID: 10955799
    [Abstract] [Full Text] [Related]

  • 18. Hematogenous cytokeratin 20 mRNA detection has prognostic impact in oral squamous cell carcinoma: preliminary results.
    Toyoshima T, Vairaktaris E, Nkenke E, Schlegel KA, Neukam FW, Ries J.
    Anticancer Res; 2009 Jan 15; 29(1):291-7. PubMed ID: 19331164
    [Abstract] [Full Text] [Related]

  • 19. A prospective evaluation of the diagnostic and potential prognostic utility of urinary human telomerase reverse transcriptase mRNA in patients with bladder cancer.
    Bowles L, Bialkowska-Hobrzanska H, Bukala B, Nott L, Razvi H.
    Can J Urol; 2004 Dec 15; 11(6):2438-44. PubMed ID: 15636669
    [Abstract] [Full Text] [Related]

  • 20. Comparative analysis of bone marrow and venous blood isolates from gastrointestinal cancer patients for the detection of disseminated tumor cells using reverse transcription PCR.
    Soeth E, Vogel I, Röder C, Juhl H, Marxsen J, Krüger U, Henne-Bruns D, Kremer B, Kalthoff H.
    Cancer Res; 1997 Aug 01; 57(15):3106-10. PubMed ID: 9242433
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.